Acadian Asset Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$178M Buy
300,204
+99,673
+50% +$49.6M 0.25% 81
2025
Q4
$97.7M Buy
200,531
+60,674
+43% +$28.3M 0.16% 130
2025
Q3
$58.6M Sell
139,857
-66,161
-32% -$22.3M 0.1% 178
2025
Q2
$59.2M Buy
206,018
+26,813
+15% +$8.01M 0.12% 157
2025
Q1
$55.2M Buy
179,205
+169,010
+1,658% +$57.9M 0.16% 133
2024
Q4
$3.59M Sell
10,195
-3,360
-25% -$1.24M 0.01% 611
2024
Q3
$4.85M Sell
13,555
-9,035
-40% -$3.05M 0.02% 511
2024
Q2
$7.19M Sell
22,590
-89,366
-80% -$23.7M 0.02% 412
2024
Q1
$25.7M Buy
111,956
+80,478
+256% +$18.2M 0.09% 179
2023
Q4
$6.91M Sell
31,478
-17,768
-36% -$4.1M 0.03% 373
2023
Q3
$11.1M Sell
49,246
-31,196
-39% -$7.19M 0.05% 273
2023
Q2
$17.7M Sell
80,442
-79,008
-50% -$17.5M 0.07% 230
2023
Q1
$35.7M Buy
159,450
+104,455
+190% +$25.8M 0.16% 157
2022
Q4
$15.3M Sell
54,995
-42,129
-43% -$10.6M 0.08% 219
2022
Q3
$20.3M Sell
97,124
-13,623
-12% -$3.05M 0.11% 175
2022
Q2
$26.1M Sell
110,747
-161,483
-59% -$32.8M 0.13% 165
2022
Q1
$48.8M Sell
272,230
-74,468
-21% -$14.2M 0.2% 125
2021
Q4
$74.9M Sell
346,698
-332,397
-49% -$65.3M 0.28% 98
2021
Q3
$125M Sell
679,095
-120,321
-15% -$23.7M 0.48% 68
2021
Q2
$143M Sell
799,416
-244,203
-23% -$46.5M 0.54% 50
2021
Q1
$175M Sell
1,043,619
-84,396
-7% -$14.1M 0.68% 29
2020
Q4
$171M Sell
1,128,015
-138,969
-11% -$18.2M 0.66% 33
2020
Q3
$128M Buy
1,266,984
+60,778
+5% +$6.67M 0.54% 47
2020
Q2
$146M Buy
1,206,206
+420,777
+54% +$47.3M 0.63% 31
2020
Q1
$74.5M Sell
785,429
-2,342
-0.3% -$223K 0.43% 57
2019
Q4
$69.4M Sell
787,771
-43,891
-5% -$3.86M 0.32% 81
2019
Q3
$66.3M Sell
831,662
-81,459
-9% -$6.56M 0.28% 94
2019
Q2
$71.3M Sell
913,121
-110,710
-11% -$10.4M 0.34% 80
2019
Q1
$120M Sell
1,023,831
-29,998
-3% -$3.5M 0.52% 58
2018
Q4
$115M Sell
1,053,829
-142,531
-12% -$16.5M 0.57% 49
2018
Q3
$153M Buy
1,196,360
+51,346
+4% +$6.35M 0.63% 40
2018
Q2
$130M Sell
1,145,014
-77,149
-6% -$8.48M 0.56% 51
2018
Q1
$137M Buy
1,222,163
+101,095
+9% +$12.8M 0.59% 48
2017
Q4
$166M Buy
1,121,068
+26,122
+2% +$3.32M 0.72% 33
2017
Q3
$128M Sell
1,094,946
-47,110
-4% -$6.02M 0.57% 49
2017
Q2
$148M Buy
1,142,056
+57,509
+5% +$7.17M 0.67% 34
2017
Q1
$147M Sell
1,084,547
-58,537
-5% -$8.87M 0.67% 34
2016
Q4
$164M Sell
1,143,084
-128,435
-10% -$16.4M 0.8% 29
2016
Q3
$150M Buy
1,271,519
+99,249
+8% +$11.9M 0.74% 29
2016
Q2
$124M Buy
1,172,270
+77,552
+7% +$8.65M 0.63% 38
2016
Q1
$122M Buy
1,094,718
+67,228
+7% +$8.51M 0.62% 35
2015
Q4
$161M Buy
1,027,490
+36,661
+4% +$5.34M 0.84% 23
2015
Q3
$130M Sell
990,829
-257,165
-21% -$41.2M 0.71% 31
2015
Q2
$217M Sell
1,247,994
-316,135
-20% -$56.9M 1.05% 19
2015
Q1
$270M Sell
1,564,129
-139,557
-8% -$21.3M 1.24% 11
2014
Q4
$221M Sell
1,703,686
-63,206
-4% -$8.15M 0.98% 23
2014
Q3
$227M Sell
1,766,892
-114,891
-6% -$11.8M 1.1% 17
2014
Q2
$167M Buy
1,881,783
+9,863
+0.5% +$948K 0.81% 24
2014
Q1
$176M Sell
1,871,920
-136,001
-7% -$13.9M 0.92% 26
2013
Q4
$227M Sell
2,007,921
-8,038
-0.4% -$725K 1.26% 18
2013
Q3
$159M Buy
2,015,959
+11,440
+0.6% +$836K 1.03% 23
2013
Q2
$132M Buy
+2,004,519
New +$129M 0.92% 30

Other funds holding UTHR